Furthermore, EBV BART6-3p behaves as an oncomiR interfering with the function of important cell signaling pathways, including NF-κB and Akt/PI3K, thus affecting the global gene expression of EBV-associated BL [112,113,114]. This evidence concerns the gene AKT1 and Burkitt lymphoma.